Novartis Faces Zometa Suit Despite Delay After Plaintiff Death
An Ohio federal judge has allowed a suit against Novartis AG over its bone drug Zometa to proceed despite a four-year gap from the time of the plaintiff's death to when...To view the full article, register now.
Already a subscriber? Click here to view full article